Skip to main content
Cidara Therapeutics, Inc. logo

Cidara Therapeutics, Inc. — Investor Relations & Filings

Ticker · CDTX ISIN · US1717572069 LEI · 549300IHQ9Z7RI1X2D22 US Manufacturing
Open in API
Filings indexed 793 across all filing types
Latest filing 2017-04-06 Investor Presentation
Country US United States of America
Listing US CDTX

About Cidara Therapeutics, Inc.

https://www.cidara.com/

Cidara Therapeutics, Inc. is a biotechnology company that develops targeted immunotherapies and novel anti-infectives for patients with serious diseases. The company utilizes its proprietary Cloudbreak® platform to create drug-Fc conjugates (DFCs). These DFCs are engineered as 'single molecule cocktails' by coupling targeted small molecules or peptides to a human antibody fragment (Fc). This approach is designed to directly inhibit disease targets, such as fungal or viral pathogens, while simultaneously engaging the patient's immune system. The company's focus is on developing therapies for the treatment and prevention of life-threatening infections and other serious conditions.

Recent filings

Filing Released Lang Actions
8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated April 6, 2017. It specifically mentions that the item 7.01 Regulation FD Disclosure includes a slide presentation attached as Exhibit 99.1, which was presented in an investor meeting by management. The document states that the slide presentation may be used in future meetings and clarifies that the information is not deemed filed for certain regulatory purposes. The key content is a slide presentation for investors, which aligns with the definition of an Investor Presentation (IP). The document length is 2822 characters, which is relatively short and primarily serves as a cover/reporting form for the presentation rather than a full financial report or earnings release. Therefore, the best classification is Investor Presentation (IP).
2017-04-06 English
FORM 4 SUBMISSION
Director's Dealing
2017-04-04 English
FORM 4 SUBMISSION
Director's Dealing
2017-04-04 English
FORM 4 SUBMISSION
Director's Dealing
2017-04-04 English
FORM 4 SUBMISSION
Director's Dealing
2017-04-04 English
FORM 4 SUBMISSION
Director's Dealing
2017-04-04 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.